Clinical Report: Neurogenic Progression May Falter in MDD

Overview

This study investigates disrupted adult hippocampal neurogenesis in patients with major depressive disorder (MDD), revealing stalled progression from neural stem-like cells to neuroblasts.

Background

Major depressive disorder (MDD) is a prevalent mental health condition characterized by various clinical manifestations, including mood alterations and cognitive impairments.

Data Highlights

No numerical data provided in the source material.

Key Findings

• Patients with MDD exhibited stalled progression in the adult hippocampal neurogenic lineage.
• There was a higher proportion of quiescent neural stem cells and fewer neuroblasts in MDD patients compared to controls.
• Stage-associated gene signatures were delayed in neural stem cells and reduced in neuroblasts among MDD patients.
• Molecular alterations included increased expression of an interferon-related gene module in early neurogenic populations in MDD.
• Proteomic profiling identified 297 differentially expressed proteins in MDD patients compared to controls.

Clinical Implications

The findings suggest that therapeutic strategies targeting neurogenesis may be relevant in managing MDD. Understanding the molecular alterations associated with disrupted neurogenic progression could inform future research and treatment approaches.

Conclusion

The study highlights significant disruptions in neurogenic processes in MDD, providing a molecular framework for further exploration of therapeutic targets in this disorder.

Related Resources & Content

1. Peng MS, et al., Nature Medicine, 2026 -- Dysregulated adult hippocampal neurogenesis in major depressive disorders
2. BMC Psychiatry (Springer) — Neurovascular coupling abnormalities in first-episode drug-naïve major depressive disorder patients
3. BMC Psychiatry (Springer) — Utilizing resting motor threshold to predict cognitive function in drug-naive patients with major depressive disorder
4. Frontiers in Neurology — Neuropsychiatric symptom profile in neurocognitive disorders and their relationship with functional decline
5. Brain — Longitudinal Alterations in Cerebral Compensation Influence the Progression of Parkinson's Disease
6. Overview | Depression in adults: treatment and management | Guidance | NICE
7. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update
8. Regional brain morphology and current antidepressant use: findings from 32 international cohorts from the ENIGMA major depressive disorder working group | Molecular Psychiatry
9. Hippocampal volume trajectory and its relation to clinical course during and following ECT-treatment in patients with depression: A systematic review and meta-analysis - PubMed
10. Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease | Nature
11. Dysregulated adult hippocampal neurogenesis in major depressive disorders | Nature Medicine
12. The brain struggles to make new neurons in people with depression | Nature